{"jsonapi":{"version":"1.0"},"data":{"type":"recalls","id":"536e39c51e3f20827c17fe9dc1792e509f4620b5a46fdb5e3e2f846a577a20de","attributes":{"feedName":"fda","feedSource":"fda","title":"Ata Int. Inc. Issues Voluntary Nationwide Recall of BLUEFUSION Capsules, due to presence of Undeclared Sildenafil, Tadalafil, Desmethyl carbodenafil, Dithiodesmethyl carbodenafil, Scutellarin and Daidzein","description":"Ata Int. Inc. is voluntarily recalling all lots within expiry of BLUEFUSION Capsules to the consumer level. FDA analysis has found the product to be tainted with sildenafil, tadalafil, desmethyl carbodenafil, dithiodesmethyl carbodenafil, scutellarin and daidzein. Sildenafil and tadalafil are FDA ap","link":"https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/ata-int-inc-issues-voluntary-nationwide-recall-bluefusion-capsules-due-presence-undeclared","publicationDate":"2019-03-21T04:00:00.000Z","state":"sent","affected":[],"allergens":[],"audience":["consumers"],"categories":["drugs"],"contaminants":["other"],"distribution":["AK","AL","AR","AZ","CA","CO","CT","DC","DE","FL","GA","HI","IA","ID","IL","IN","KS","KY","LA","MA","MD","ME","MI","MN","MO","MS","MT","NC","ND","NE","NH","NJ","NM","NV","NY","OH","OK","OR","PA","RI","SC","SD","TN","TX","UT","VA","VT","WA","WI","WV","WY"],"risk":"possible","token":"5d9e68bd8b079e002a25181e"}}}